Income StatementBalance SheetCash FlowSegments
Caterpillar logo

Caterpillar Balance Sheet Statement

Assets, liabilities, and shareholders' equity

Caterpillar holds $95.6B in total assets. Cash and equivalents total $4.1B. The current ratio is 1.35. Based on the Q1 2026 filing.

Total Assets$95.6BTotal Stockholders Equity21.3BLong Term Debt$30.7BCash And Equivalents$4.1BTotal Current Assets$48.6BTotal Current Liabilities$35.9B
Latest FilingQ1 2026
Report Date2026-05-06
Market Cap$405.27B
P/E Ratio42.99

Current Assets

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Accounts receivable, net$9.3B$9.1B$9.7B$10.1B$10.9B$11.4B
Available-for-Sale Debt Securities - Amortized Cost$4.1B———$744.0M—
Available-for-Sale Debt Securities - Amortized Cost (Due Within One Year)$1.3B———$744.0M—
Available-for-Sale Debt Securities - Unrealized Loss Position (>=12 Months)$75.0M———$26.0M—
AFS and Trading Securities - Unrealized Loss Position (>=12 Months)$1.3B———$763.0M—
AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value$875.0M———$177.0M—
Available-for-Sale Debt Securities - Unrealized Loss Position (<12 Months)$6.0M———$0.0—
Available-for-Sale Debt Securities - Unrealized Loss Position$81.0M———$26.0M—
AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Fair Value$1.3B———$763.0M—
AFS and Trading Securities - Unrealized Loss Position Fair Value$2.2B———$940.0M—
AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value$875.0M———$177.0M—
Allowance for Credit Losses - Receivable (Current)$262.0M———$277.0M—
Cash and cash equivalents$6.9B$3.6B$5.4B$7.5B$10.0B$4.1B
Cash, Cash Equivalents, and Marketable Securities$2.2B———$940.0M—
Finished goods$8.3B———$8.7B—
Inventory Supplies Net Of Reserves$379.0M———$378.0M—
Derivative Assets - Fair Value$462.0M———$496.0M—
Derivative Assets - Net Reduction from Master Netting Arrangements$186.0M———$160.0M—
Equipment Installment Plan Receivables, Gross$23.0B———$25.2B—
Derivative assets$276.0M———$336.0M—
Trading assets$1.3B———$748.0M—
Finance Receivables (Current)$9.6B$9.7B$10.1B$10.3B$10.6B$10.4B
Financing Receivables$23.0B———$25.2B—
Finished goods$8.3B———$8.7B—
Raw materials$6.7B———$7.4B—
Work in process$1.4B———$1.6B—
Percentage of Inventory on LIFO Basis65.0%———70.0%—
Inventory LIFO Reserve$3.9B———$4.3B—
Operating Lease Income - 2022 (Lessor)$868.0M———$896.0M—
Operating Lease Income - 2025 (Lessor)$176.0M———$200.0M—
Prepaid expenses and other current assets$3.1B$2.8B$2.9B$2.9B$2.8B$3.0B
Total current assets$45.7B$43.0B$46.8B$49.8B$52.5B$48.6B

Current Liabilities

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Accrued Manufacturing Costs$2.4B$1.3B$1.6B$2.1B$2.6B$1.4B
Other Commercial Liabilities$5.2B$5.0B$5.2B$5.2B$5.6B$5.5B
Commercial Paper Outstanding$3.9B———$5.4B—
Contract liabilities$2.7B———$4.7B—
Accrued Liabilities, Current$5.2B$5.0B$5.2B$5.2B$5.6B$5.5B
Compensation and benefits$2.4B$1.3B$1.6B$2.1B$2.6B$1.4B
Other accrued liabilities$2.9B$2.8B$2.6B$2.8B$2.8B$2.6B
Current portion of long-term debt$4.4B———$5.5B—
Deferred revenue$2.3B$3.0B$3.4B$3.4B$3.3B$4.4B
Derivative Liabilities - Fair Value$385.0M———$165.0M—
Derivative Liabilities - Not Offset Policy Election Deduction$186.0M———$160.0M—
Derivative Liabilities Offset$186.0M———$160.0M—
Dividends payable$674.0M$0.0$707.0M$0.0$703.0M$0.0
Derivative liabilities$385.0M———$165.0M—
Lease Liability Payments - 2021$868.0M———$896.0M—
Operating Lease Liability Payments - 2024 (Lessee)$120.0M———$149.0M—
Operating Lease Liability Payments - 2025 (Lessee)$67.0M———$98.0M—
Lease Liability Payments - Due Year Two$120.0M———$149.0M—
Lease Liability Payments - Due Year Three$93.0M———$115.0M—
Lease Liability Payments - Due Year Four$67.0M———$98.0M—
Lease Liability Payments - Remainder of Fiscal Year$157.0M———$183.0M—
Operating lease liabilities, current$143.0M———$158.0M—
Operating Lease Liability Payments Due$679.0M———$842.0M—
Operating Lease Liability - Undiscounted Excess Amount$77.0M———$114.0M—
Standard Product Warranty Accrual$1.7B———$1.6B—
Supplier Finance Program Obligations83000000000.0%———93600000000.0%—
Total current liabilities$32.3B$32.6B$34.9B$36.0B$36.6B$35.9B

Non-Current Assets

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Accumulated Goodwill Impairment Losses$2.1B———$2.1B—
Available-for-Sale Debt Securities - Fair Value (Maturing 1 to 5 Years)$1.8B———$1.5B—
Deferred Tax Assets and Other Non-Current Assets$622.0M$4.8B$5.2B$5.4B$579.0M$6.2B
Equipment Installment Plan Receivables (Non-Current), Net$13.2B$13.5B$13.8B$14.0B$14.3B$14.3B
Available-for-sale securities$1.8B———$1.5B—
Finite-Lived Intangible Assets - Expected Amortization Expense (Year One)$23.0M———$21.0M—
Finite-Lived Intangible Assets - Expected Amortization Expense (Year Five)$55.0M———$36.0M—
Finite Lived Intangible Assets - Gross$2.8B———$2.6B—
Goodwill$5.2B$5.3B$5.3B$5.3B$5.3B$5.9B
Investments - Amortized Cost Basis$4.1B———$3.5B—
Net Investment in Lease$2.0B———$2.3B—
Net Operating Loss Carryforwards$1.3B———$1.3B—
Intangible assets &#8212; net$399.0M———$241.0M—
Other intangible assets&#8212;net$399.0M$361.0M$321.0M$281.0M$241.0M$419.0M
Noncurrent deferred and refundable income taxes$3.3B$3.3B$3.4B$3.0B$2.9B$2.4B
Long-term financing receivables (net of allowances of $27 in 2026 and $34 in 2025)$13.2B$13.5B$13.8B$14.0B$14.3B$14.3B
Operating lease right-of-use assets$592.0M———$708.0M—
Other non-current assets$5.3B$4.8B$5.2B$5.4B$6.1B$6.2B
Property, plant and equipment at cost$29.5B———$31.9B—
Operating Lease Income - 2026 (Lessor)$67.0M———$104.0M—
Operating Lease Income - 2027 (Lessor)$317.0M———$397.0M—
Operating Lease Income - 2028 (Lessor)$176.0M———$200.0M—
Operating Lease Income - 2029 (Lessor)$67.0M———$104.0M—
Operating Lease Income - Thereafter (Lessor)$37.0M———$80.0M—
Operating lease right-of-use assets3.0%———4.0%—
Operating Lease Right-of-Use Assets in Other Assets$592.0M———$708.0M—
Accumulated depreciation$16.1B———$16.8B—
Property and equipment, net$13.4B$13.4B$13.9B$14.3B$15.1B$15.2B
Software and Technology Licenses, Net$5.3B$4.8B$5.2B$5.4B$6.1B$6.2B
Tax Credit Carryforward Valuation Allowance$874.0M———$840.0M—
Total assets$87.8B$85.0B$90.3B$93.7B$98.6B$95.6B

Equity

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Accumulated Loss$75.0M———$26.0M—
Accumulated other comprehensive income (loss)-$2.5B-$2.2B-$1.7B-$1.7B-$1.8B-$1.9B
Common Stock Shares Outstanding$625.0M———$1.1B—
Cumulative Gross Losses and Impairments$2.1B———$2.1B—
Common stock$6.9B$6.0B$6.1B$6.2B$7.2B$5.9B
Treasury Stock, Value$44.3B$47.1B$48.0B$48.3B$49.5B$53.3B
ESOP Allocated Shares10.4M———9.6M—
Investments - Gross Unrealized Losses$2.2B———$940.0M—
Number of Exercisable Options$509.0M———$867.0M—
Retained earnings$59.4B$61.4B$62.2B$64.5B$65.4B$68.0B
Share-Based Payment Award Options Outstanding - Number3.7M———3M—
Share-Based Payment - Unrecognized Cost of Nonvested Awards$148.0M———$209.1M—
Shares Reserved for Future Issuance Under Stock Plans40.9M———39.3M—
Total liabilities and stockholders' equity$87.8B$85.0B$90.3B$93.7B$98.6B$95.6B
Total stockholders' equity19.5B———21.3B—
Unrealized Gains on Investments-$72.0M———$14.0M—
Weighted Average Exercise Price of Exercisable Options$167.72———$192.44—
Weighted Average Exercise Price of Outstanding Options$195.28———$220.52—

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Aggregate Notional Principal Outstanding$27.0B———$29.3B—
Nonperforming Loans and Leases Percentage$23.0B———$25.2B—
Cumulative Cost Basis$4.1B———$3.5B—
Deferred Revenue Timing Percentage50.0%———50.0%—
Derivative Notional Amount$27.0B———$29.3B—
Fair Value Measurement Disclosure$571.0M———$325.0M—
Gross Assets/Liabilities$571.0M———$325.0M—
Guarantor Obligations - Maximum Exposure$368.0M———$458.0M—
Indemnification Liability Maximum Exposure$368.0M———$458.0M—
Line of Credit Maximum Borrowing Capacity$14.6B———$15.8B—
Line of Credit Remaining Borrowing Capacity$9.9B———$9.7B—
Operating Lease Income - 2023 (Lessor)$317.0M———$397.0M—
Operating Lease Income - 2024 (Lessor)$317.0M———$397.0M—
Long-term accounts receivable, net————$2.1B$2.5B
Total$4.1B———$3.5B—
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10$304.0M———$378.0M—
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10$301.0M———$383.0M—
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five$1.8B———$1.5B—
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five$1.8B———$1.5B—
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10$102.0M———$202.0M—
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10$102.0M———$202.0M—
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One$1.3B———$744.0M—
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One$1.3B———$748.0M—
Available for sale investments$4.0B———$3.5B—
Common Stock, Shares, Outstanding$477.9M———$465.3M—
Contract with Customer, Asset, after Allowance for Credit Loss$238.0M———$297.0M—
Contract with Customer, Liability$2.7B———$4.7B—
Non-current retainage balances$640.0M———$1.0B—
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss$75.0M———$26.0M—
Less than 12 months$875.0M———$177.0M—
12 months or more$1.3B———$763.0M—
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss$6.0M———$0.0—
Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss$81.0M———$26.0M—
Debt Securities, Available-for-Sale, Unrealized Loss Position$2.2B———$940.0M—
Deferred Tax Liabilities, Gross$1.7B———$1.8B—
Deferred income taxes$432.0M———$494.0M—
Deferred Tax Assets, Gross$5.4B———$4.9B—
Deferred Tax Assets, Net$2.8B———$2.3B—
Deferred Tax Assets, Net of Valuation Allowance$3.2B———$2.8B—
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Postretirement Benefits$560.0M———$425.0M—
Deferred Tax Assets, Valuation Allowance$874.0M———$840.0M—
Deferred Tax Liabilities, Other$454.0M———$429.0M—
Defined Benefit Plan, Expected Gross Prescription Drug Subsidy Receipts$46.0M———$42.0M—
Derivative, gross, assets$462.0M———$496.0M—
Derivative Asset, Including Not Subject to Master Netting Arrangement, after Offset and Deduction$276.0M———$336.0M—
Derivatives, gross, liabilities$571.0M———$325.0M—
Derivative Liability, Including Not Subject to Master Netting Arrangement, after Offset and Deduction$385.0M———$165.0M—
Potential reduction in net position of total derivative liabilities$186.0M———$160.0M—
Notional$27.0B———$29.3B—
Unrecognized compensation cost related to non-vested awards$148.0M———$209.1M—
Finite-Lived Intangible Assets, Accumulated Amortization$2.4B———$2.4B—
2028$96.0M———$35.0M—
2030$26.0M———$24.0M—
2031$23.0M———$21.0M—
2027$166.0M———$98.0M—
2029$33.0M———$27.0M—
Finite Lived Intangible Assets Amortization Expense After Year Five$55.0M———$36.0M—
Gross Carrying Amount$2.8B———$2.6B—
Goodwill, Gross$7.4B———$7.4B—
Goodwill accumulated impairment losses$2.1B———$2.1B—
Value of financial guarantee (up to)$368.0M———$458.0M—
Lessee Operating Lease Liability Payments Due$679.0M———$842.0M—
Lessee Operating Lease Liability Undiscounted Excess Amount$77.0M———$114.0M—
Amount outstanding under the credit facility$687.0M———$771.0M—
Committed Revolving Credit Facilities$14.6B———$15.8B—
2028$8.5B———$8.9B—
2029$7.8B———$7.7B—
2029$2.6B———$1.3B—
2030$214.0M———$3.1B—
2027$6.7B———$7.1B—
Noncontrolling interests in subsidiaries$3.0M$3.0M$2.0M$1.0M$0.0-$1.0M
Operating Lease Weighted Average Discount Rate Percent$0.0———$0.0—
Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, after Year Five$19.0M———$17.0M—
Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year One$6.0M———$6.0M—
Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Five$5.0M———$4.0M—
Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Four$5.0M———$5.0M—
Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Three$5.0M———$5.0M—
Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Two$6.0M———$5.0M—
Standard and Extended Product Warranty Accrual$1.7B———$1.6B—
Remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied$15.2B———$30.1B—
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number$3.7M———$3.0M—
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price$195.3———$220.5—
Incentive stock program, shares reserved for future grants (in shares)$40.9M———$39.3M—
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value$625.0M———$1.1B—
Shares reserved for awards to employees and outside directors (in shares)$42.5M———$42.5M—
Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable$2.6M———$2.3M—
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value$509.0M———$867.0M—
Supplier finance program, obligation$830.0M———$936.0M—
Treasury stock, shares (in shares)$337.0M———$349.6M—
Unrecognized tax benefits$1.3B———$1.3B—
Amount that if recognized, would affect the effective tax rate or regulatory liability$1.1B———$1.2B—
Sublease Income - Thereafter$37.0M———$80.0M—

Non-Current Liabilities

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Carrying Amount of Hedged Term Debt$5.8B———$6.1B—
Debt Instrument Face Amount$687.0M———$771.0M—
Debt Maturity - 2027$2.6B———$1.3B—
Debt Maturity - 5 to 10 Years$301.0M———$383.0M—
Debt Maturity - Over 10 Years$102.0M———$202.0M—
Deferred tax liabilities$1.7B———$1.8B—
Defined Benefit Pension Plan Liabilities (Non-Current)$3.8B$3.6B$3.6B$3.7B$3.8B$3.7B
Hedged Liability - Fair Value Hedge-$186.0M———-$34.0M—
Operating Lease Liability Payments - 2026 (Lessee)$93.0M———$115.0M—
Operating Lease Liability Payments - 2027 (Lessee)$55.0M———$74.0M—
Operating Lease Liability Payments - 2028 (Lessee)$67.0M———$98.0M—
Operating Lease Liability Payments - 2029 (Lessee)$55.0M———$74.0M—
Lease Liability Payments - Due After Year Five$187.0M———$223.0M—
Operating Lease Liability Payments - Thereafter (Lessee)$187.0M———$223.0M—
Liability, Pension and Other Postretirement and Postemployment Benefits, Noncurrent$3.8B$3.6B$3.6B$3.7B$3.8B$3.7B
Operating lease liabilities, non-current$459.0M———$570.0M—
Other non-current liabilities$4.9B$4.9B$5.2B$5.7B$6.2B$6.7B
Total liabilities$68.3B$66.9B$71.7B$73.1B$77.3B$76.9B
Unrecognized Tax Benefits$1.3B———$1.3B—
Unrecognized Tax Benefits - Impacting Effective Tax Rate$1.1B———$1.2B—
Unrecognized Tax Benefits - Income Tax Penalties and Interest Accrued$190.0M———$268.0M—